Cargando…
Long-Term Cardiac Disease- and Cancer-Associated Mortalities in Patients With Non-Metastatic Stomach Adenocarcinoma Receiving Resection and Chemotherapy: A Large Competing-Risk Population-Based Cohort Study
BACKGROUND: The survival of patients with non-metastatic gastric adenocarcinoma (nmGaC), who are receiving more and more frequently chemotherapy, has improved throughout the last decades, while treatment-caused cardiotoxicity remains a major concern. This study aimed to investigate competing causes...
Autores principales: | Huang, Lei, Shi, Yan, Zhao, Ya Jie, Wang, Lei, Hu, Wei Guo, Zhu, Zheng Gang, Zhang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076150/ https://www.ncbi.nlm.nih.gov/pubmed/35571338 http://dx.doi.org/10.14740/wjon1445 |
Ejemplares similares
-
Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020) -
Cutaneous metastatic adenocarcinoma of stomach--nodular and inflammatory carcinoma.
por: Choi, H. M., et al.
Publicado: (1986) -
Gastrointestinal Bleeding from Metastatic Prostate Adenocarcinoma to the Stomach
por: Koop, Andree, et al.
Publicado: (2017) -
Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
por: Hsu, Andrew, et al.
Publicado: (2020) -
Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting
por: Nakayama, Izuma, et al.
Publicado: (2020)